Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs

Since the approval of modifying therapies for Spinal Muscular Atrophy (SMA), several protocols aiming to screen SMN1 homozygous deletion in a neonatal context have been published. However, no work has compared different methodologies along with detailed implementation costs for centers where the neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanelli Tavares, Vanessa Luiza, Monfardini, Frederico, Lourenço, Naila Cristina Vilaça, da Rocha, Katia Maria, Weinmann, Karina, Pavanello, Rita, Zatz, Mayana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396021/
https://www.ncbi.nlm.nih.gov/pubmed/34449526
http://dx.doi.org/10.3390/ijns7030053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396021/
https://www.ncbi.nlm.nih.gov/pubmed/34449526
http://dx.doi.org/10.3390/ijns7030053

Ejemplares similares